1.Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
Hokyou LEE ; Gyuri KIM ; Young Ju CHOI ; Byung Wook HUH ; Byung-Wan LEE ; Eun Seok KANG ; Bong-Soo CHA ; Eun Jig LEE ; Yong-ho LEE ; Kap Bum HUH
Diabetes & Metabolism Journal 2020;44(2):267-276
Background:
Impaired diastolic heart function has been observed in persons with non-alcoholic fatty liver disease (NAFLD) and/or with type 2 diabetes mellitus (T2DM). However, it is unclear whether NAFLD fibrotic progression, i.e., non-alcoholic steatohepatitis, poses an independent risk for diastolic dysfunction in T2DM. We investigated the association between liver fibrosis and left ventricular (LV) diastolic dysfunction in T2DM.
Methods:
We analyzed 606 patients with T2DM, aged ≥50 years, who had undergone liver ultrasonography and pulsed-wave Doppler echocardiography. Insulin sensitivity was measured by short insulin tolerance test. Presence of NAFLD and/or advanced liver fibrosis was determined by abdominal ultrasonography and NAFLD fibrosis score (NFS). LV diastolic dysfunction was defined according to transmitral peak early to late ventricular filling (E/A) ratio and deceleration time, using echocardiography.
Results:
LV diastolic dysfunction was significantly more prevalent in the NAFLD versus non-NAFLD group (59.7% vs. 49.0%, P=0.011). When NAFLD was stratified by NFS, subjects with advanced liver fibrosis exhibited a higher prevalence of diastolic dysfunction (49.0%, 50.7%, 61.8%; none, simple steatosis, advanced fibrosis, respectively; P for trend=0.003). In multivariable logistic regression, liver fibrosis was independently associated with diastolic dysfunction (odds ratio [OR], 1.58; 95% confidence interval [CI], 1.07 to 2.34; P=0.022) after adjusting for insulin resistance and cardiometabolic risk factors. This association remained significant in patients without insulin resistance (OR, 4.32; 95% CI, 1.73 to 11.51; P=0.002).
Conclusions
Liver fibrosis was associated with LV diastolic dysfunction in patients with T2DM and may be an independent risk factor for diastolic dysfunction, especially in patients without systemic insulin resistance.
2.Report on the Project for Establishment of the Standardized Korean Laboratory Terminology Database, 2015.
Bo Kyeung JUNG ; Jeeyong KIM ; Chi Hyun CHO ; Ju Yeon KIM ; Myung Hyun NAM ; Bong Kyung SHIN ; Eun Youn RHO ; Sollip KIM ; Heungsup SUNG ; Shinyoung KIM ; Chang Seok KI ; Min Jung PARK ; Kap No LEE ; Soo Young YOON
Journal of Korean Medical Science 2017;32(4):695-699
The National Health Information Standards Committee was established in 2004 in Korea. The practical subcommittee for laboratory test terminology was placed in charge of standardizing laboratory medicine terminology in Korean. We aimed to establish a standardized Korean laboratory terminology database, Korea-Logical Observation Identifier Names and Codes (K-LOINC) based on former products sponsored by this committee. The primary product was revised based on the opinions of specialists. Next, we mapped the electronic data interchange (EDI) codes that were revised in 2014, to the corresponding K-LOINC. We established a database of synonyms, including the laboratory codes of three reference laboratories and four tertiary hospitals in Korea. Furthermore, we supplemented the clinical microbiology section of K-LOINC using an alternative mapping strategy. We investigated other systems that utilize laboratory codes in order to investigate the compatibility of K-LOINC with statistical standards for a number of tests. A total of 48,990 laboratory codes were adopted (21,539 new and 16,330 revised). All of the LOINC synonyms were translated into Korean, and 39,347 Korean synonyms were added. Moreover, 21,773 synonyms were added from reference laboratories and tertiary hospitals. Alternative strategies were established for mapping within the microbiology domain. When we applied these to a smaller hospital, the mapping rate was successfully increased. Finally, we confirmed K-LOINC compatibility with other statistical standards, including a newly proposed EDI code system. This project successfully established an up-to-date standardized Korean laboratory terminology database, as well as an updated EDI mapping to facilitate the introduction of standard terminology into institutions.
3.Association of Abdominal Obesity with Atherosclerosis in Type 2 Diabetes Mellitus (T2DM) in Korea.
Minho CHO ; Jong Suk PARK ; Jisun NAM ; Chul Sik KIM ; Jae Hyun NAM ; Hai Jin KIM ; Chul Woo AHN ; Bong Soo CHA ; Sung Kil LIM ; Kyung Rae KIM ; Hyun Chul LEE ; Kap Bum HUH
Journal of Korean Medical Science 2008;23(5):781-788
The aim of this study was to investigate the relationship between obesity, insulin resistance and atherosclerosis in type 2 diabetes mellitus (T2DM) patients. Total 530 patients with T2DM were included. To evaluate the severity of atherosclerosis, we measured the coronary artery calcification (CAC) score, intima-media thickness (IMT) of the common carotid artery, and the ankle-brachial pressure index (ABPI). Subjects were classified according to body mass index (BMI), a marker of general obesity, and waist-to-hip ratio (WHR), a marker of regional obesity. The insulin sensitivity index (ISI) was measured by the short insulin tolerance test. All subjects were classified into four groups, according to BMI: the under-weight group, the normal-weight (NW) group, the over-weight (OW) group, and the obese (OB) group. WHR and systolic blood pressure, triglycerides (TG), HDL-cholesterol (HDLC), free fatty acids (FFA), fibrinogen, and fasting c-peptide levels were significantly different between BMI groups. TG, HDL-C, FFA, fibrinogen and ISI were significantly different between patients with and without abdominal obesity. In the OW group as well as in the NW group, carotid IMT, ABPI and CAC score were significantly different between patients with and without abdominal obesity. This study indicates that abdominal obesity was associated with atherosclerosis in T2DM patients.
Aged
;
Atherosclerosis/complications
;
Blood Pressure
;
Coronary Vessels/pathology
;
Diabetes Complications
;
Diabetes Mellitus, Type 2/*genetics
;
Female
;
Humans
;
Insulin Resistance
;
Korea
;
Male
;
Middle Aged
;
Obesity/*complications/*genetics
;
Triglycerides/metabolism
;
Tunica Intima/pathology
;
Tunica Media/pathology
4.Visceral Fat Thickness Predicts Fatty Liver in Koreans with Type 2 Diabetes Mellitus.
Hai Jin KIM ; Min Ho CHO ; Jong Suk PARK ; Ji Sun NAM ; Eun Seok KANG ; Chul Woo AHN ; Bong Soo CHA ; Eun Jig LEE ; Sung Kil LIM ; Kyung Rae KIM ; Hyun Chul LEE ; Kap Bum HUH
Journal of Korean Medical Science 2008;23(2):256-261
Our aim was to study whether visceral adiposity is a predictor of diabetic fatty liver in Korean type 2 diabetes mellitus. In this study, abdominal ultrasonography was used to assess the presence of fatty liver in 1,898 patients with type 2 diabetes. We measured visceral fat thickness by high-resolutional ultrasonography and insulin resistance by Kitt. Half of the cohort had a fatty liver (50.2%). High visceral fat thickness had the highest odds ratio for developing fatty liver in both sexes (odds ratio [S.D]: 3.14 [2.24-4.69], p<0.00 in male, 2.84 [2.04-3.93], p<0.00 in female). In addition, visceral fat thickness of 42.45 and 37.7 mm in men and women, respectively, were chosen as the discriminating value to predict the presence of fatty liver with a sensitivity of 71% and 73% and a specificity of 70% and 70% in men and women, respectively. The area under the receiver-operating characteristics curve was 0.759 in men and 0.764 in women. Therefore we could conclude that the degree of visceral adiposity predicts the presence of fatty liver type 2 diabetes mellitus, whether centrally obese or not, suggesting that hepatic fat accumulation in a diabetic fatty liver may be influenced by visceral fat accumulation regardless of waist circumference.
Aged
;
Aorta/pathology
;
Cohort Studies
;
Diabetes Complications/*diagnosis
;
Diabetes Mellitus, Type 2/*diagnosis/pathology
;
Fatty Liver/*complications/*diagnosis
;
Female
;
Humans
;
Intra-Abdominal Fat/*pathology
;
Male
;
Middle Aged
;
Models, Statistical
;
Odds Ratio
;
ROC Curve
;
Sensitivity and Specificity
5.The Relation between Birth Weight and Insulin Resistance in Korean Adolescents.
Chul Sik KIM ; Jong Suk PARK ; Jina PARK ; Ji Sun NAM ; Eun Seok KANG ; Chul Woo AHN ; Bong Soo CHA ; Sung Kil LIM ; Kyung Rae KIM ; Hyun Chul LEE ; Kap Bum HUH ; Dae Jung KIM
Yonsei Medical Journal 2006;47(1):85-92
Low birth weight is associated with insulin resistance and type 2 diabetes in adults. The fetal programming hypothesis has shown that insulin resistance and its associated metabolic disturbances result from a poor gestational environment, for which low birth weight is a surrogate. An at-home questionnaire survey was performed on 660 middle school students (12-15 years) in Seoul, Korea, and 152 cases were randomly selected based on their birth weight. Subjects were divided into three groups according to birth weight. We recorded their birth weight and measured their current anthropometric data, blood pressure, lipid profile, HOMA-IR, and HOMA-beta, and compared these parameters among the groups. The relation of birth weight to physiological characteristics in adolescence was examined. Systolic blood pressure, lipid profiles, and fasting plasma glucose, HOMA-beta were not significantly different among the groups, but diastolic blood pressure was lower in the third tertile. Insulin, C-peptide, and HOMA-IR were higher in the lower birth weight tertile. After adjustment for confounding factors, birth weight was inversely related to diastolic blood pressure, insulin, C-peptide, and HOMA-IR. We conclude that low birth weight may predict the risk of the insulin resistance and its progression over age, and that adequate gestational nutrition is therefore necessary to prevent low birth weight.
Male
;
Korea/epidemiology
;
Insulin-Secreting Cells/physiology
;
*Insulin Resistance
;
Insulin/blood
;
Hyperinsulinism/epidemiology/etiology/metabolism
;
Humans
;
Female
;
Child
;
C-Peptide/blood
;
Blood Pressure
;
*Birth Weight
;
Adolescent
6.zVAD-fmk, unlike BocD-fmk, does not inhibit caspase-6 acting on 14-3-3/Bad pathway in apoptosis of p815 mastocytoma cells.
Su Bog YEE ; Soo Jin BAEK ; Hwan Tae PARK ; Seung Hun JEONG ; Jin Hee JEONG ; Tae Hyun KIM ; Jong Min KIM ; Byung Kap JEONG ; Bong Soo PARK ; Taeg Kyu KWON ; Il YOON ; Young Hyun YOO
Experimental & Molecular Medicine 2006;38(6):634-642
In a preliminary study, we found that benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD- fmk), unlike Boc-aspartyl(OMe)-fluoromethylketone (BocD-fmk), at usual dosage could not prevent genistein-induced apoptosis of p815 mastocytoma cells. This study was undertaken to reveal the mechanism underlying the incapability of zVAD-fmk in preventing this type of apoptosis. We observed that 14-3-3 protein level was reduced in genistein-treated cells and that BocD-fmk but not zVAD-fmk prevented the reduction of 14-3-3 protein level and the release of Bad from 14-3-3. We also demonstrated that truncated Bad to Bcl-xL interaction in genistein- treated cells was prevented by BocD-fmk but not by zVAD-fmk treatment. Our data indicate that BocD- fmk, compared to zVAD-fmk, has a certain preference for inhibiting 14-3-3/Bad signalling pathway. We also elucidated that this differential efficacy of BocD-fmk and zVAD-fmk resulted from the different effect in inhibiting caspase-6 and that co-treatment of zVAD-fmk and caspase-6 specific inhibitor substantially prevented genistein-induced apoptosis. Our data shows that caspase-6 plays a role on Bad/14-3-3 pathway in genistein-induced apoptosis of p815 cells, and that the usual dose of zVAD-fmk, in contrast to BocD-fmk, did not prevent caspase-6 acting on 14-3-3/Bad-mediated event.
bcl-Associated Death Protein/*metabolism
;
*Signal Transduction/drug effects
;
Mitochondria/drug effects
;
Mice
;
Mastocytoma
;
Hydrocarbons, Fluorinated/*pharmacology
;
Genistein/pharmacology
;
Enzyme Inhibitors/*pharmacology
;
Cell Line, Tumor
;
Caspase 6/antagonists & inhibitors/*metabolism
;
Benzyl Compounds/*pharmacology
;
Apoptosis/*drug effects
;
Animals
;
Amino Acid Chloromethyl Ketones/pharmacology
;
14-3-3 Proteins/*metabolism
7.Characteristics of Type 2 Diabetes in Terms of Insulin Resistance in Korea.
Jong Suk PARK ; Chul Sik KIM ; Joo Young NAM ; Dol Mi KIM ; Min Ho JO ; Jina PARK ; Chul Woo AHN ; Bong Soo CHA ; Sung Kil LIM ; Kyung Rae KIM ; Hyun Chul LEE ; Kap Bum HUH
Yonsei Medical Journal 2005;46(4):484-490
The aim of this study was to assess the implications of insulin resistance on the clinical and biochemical profiles of Korean type 2 diabetic patients. 122 patients with type 2 diabetes underwent a short insulin tolerance test to assess insulin resistance. Subjects were classified in tertiles according to ISI (insulin sensitivity index), and the tertile I (the insulin- resistant group) and tertile III (the insulin-sensitive group) clinical and biochemical parameters were compared. Age, waist circumference (WC), systolic blood pressure (SBP), HbA1c, body fat content, and fasting plasma glucose were significantly higher in tertile I than tertile III (all p < 0.05). The frequency of hypertension and family history of cerebrovascular disease (CVD) were greater in tertile I than III (p < 0.05). To evaluate the factors affecting ISI, multiple regression was performed, and age, WC, SBP, HbA1c, and body fat content were found to be independently related to insulin resistance (p < 0.05). Old age, hypertension, central obesity, and poor glycemic control were identified as clinical parameters of insulin resistance in Korean type 2 diabetic patients.
Adult
;
Aged
;
Blood Glucose/analysis
;
C-Peptide/analysis
;
Diabetes Mellitus, Type 2/*metabolism
;
Female
;
Hemoglobin A, Glycosylated/analysis
;
Humans
;
*Insulin Resistance
;
Lipoproteins, HDL Cholesterol/blood
;
Male
;
Middle Aged
;
Research Support, Non-U.S. Gov't
8.The Prevalence of the Metabolic Syndrome in Korean Adults: Comparison of WHO and NCEP Criteria.
Sung Hee CHOI ; Chul Woo AHN ; Bong Soo CHA ; Yoon Sok CHUNG ; Kwan Woo LEE ; Hyun Chul LEE ; Kap Bum HUH ; Dae Jung KIM
Yonsei Medical Journal 2005;46(2):198-205
The aims of this study were to compare the prevalence of the metabolic syndrome according to the WHO and NCEP ATP III criteria in Korean adults, and to compare the prevalence of the metabolic syndrome with the results in previous Korean studies. The study comprised 1, 230 subjects (627 men, 603 women) aged 30-79 years (mean 52.4+/-10.3 years) who underwent medical check-up from April to June, 2001 in the Korea Association of Health (KAH). The prevalence of the metabolic syndrome according to the modified WHO criteria was 21.8% of men and 19.4% of women. However, the prevalence was increased 1.6 times (34.2%) in men and 2.0 times (38.7%) in women using the modified NCEP criteria. The prevalence of the metabolic syndrome has varied widely according to differences in the criteria. Thus, further studies are necessary to define the appropriate criteria of the metabolic syndrome for Korean adults.
Adult
;
Aged
;
Asian Continental Ancestry Group/*statistics & numerical data
;
*Cholesterol
;
Comparative Study
;
Female
;
*Health Education
;
Humans
;
Korea/epidemiology
;
Male
;
Metabolic Syndrome X/*diagnosis/*epidemiology
;
Middle Aged
;
Practice Guidelines
;
Prevalence
;
*World Health Organization
9.The Correlation between Insulin Resistance and the Visceral Fat to Skeletal Muscle Ratio in Middle-aged Women.
Chul Sik KIM ; Joo Young NAM ; Jong Suk PARK ; Dol Mi KIM ; Soo Jee YOON ; Chul Woo AHN ; Sung Kil LIM ; Kyung Rae KIM ; Hyun Chul LEE ; Kap Bum HUH ; Bong Soo CHA
Yonsei Medical Journal 2004;45(3):469-478
Central obesity with visceral fat accumulation and the amount of skeletal muscle mass may influence insulin sensitivity via its capacity for glucose load uptake. We investigated the relationships among the following metabolic variables: ratio of fat area to skeletal muscle area (VMR), percent ideal body weight, body mass index, waist-to-hip circumference (WHR) and visceral fat to subcutaneous fat ratio (VSR) in 114 nondiabetic middle-aged women. Anthropometric parameters, lipid profiles and sex hormone- binding globulin were measured. Visceral and subcutaneous fat areas at the umbilical level and the skeletal muscle area at the mid-thigh level were measured and computed. 75-gram OGTT tests were performed, along with measuring plasma glucose, insulin and free fatty acid levels, according to which area under the curve of glucose (Glu-AUC), insulin (Ins-AUC), free fatty acid (FFA-AUC) and glucose/insulin ratio (GIR=Glu- AUC/Ins-AUC), were calculated. 1) Triglyceride was more correlated with VSR than VMR. 2) The independent anthropometric parameters for each metabolic variable were In conclusion, VMR for Ins-AUC, WHR for Glu-AUC and total cholesterol, and VSR for triglyceride. 3) For subjects with higher VMR, age, Ins-AUC and triglyceride were significantly higher. 4) Subjects with higher VMR were older and showed higher Ins-AUC and lower GIR than the subjects with lower VMR. In conclusion, VMR is an anthropometric parameter that reflects insulin resistance concerning glucose metabolism, and VSR is thought to be a good parameter that that reflects the serum lipid levels. Further prospective studies are necessary to reevaluate the visceral fat vs. skeletal muscle relationship.
Adipose Tissue/*metabolism/*pathology
;
Adult
;
Body Constitution
;
*Body Mass Index
;
Female
;
Human
;
*Insulin Resistance
;
Menopause
;
Middle Aged
;
Muscle, Skeletal/*metabolism
;
Obesity/metabolism/pathology
;
Postmenopause
;
Viscera
10.Graves' Disease Associated with Klinefelter's Syndrome.
Jong Suk PARK ; Chul Sik KIM ; Joo Young NAM ; Dol Mi KIM ; Soo Jee YOON ; Chul Woo AHN ; Bong Soo CHA ; Sung Kil LIM ; Kyung Rae KIM ; Hyun Chul LEE ; Kap Bum HUH
Yonsei Medical Journal 2004;45(2):341-344
Klinefelter's syndrome is one of the most common forms of primary hypogonadism and infertility in males. It is characterized by small and firm testes, gynecomastia, azoospermia, and an elevated gonadotropin level. The frequencies of diabetes mellitus, breast cancer, and germ cell neoplasia increases in Klinefelter's syndrome. We report upon a 35 year-old male patient with Graves' disease in association with Klinefelter's syndrome; as confirmed by chromosome analysis. The patient is being treated with antithyroid medication for Graves' disease and by testosterone replacement for Klinefelter's syndrome.
Adult
;
Graves' Disease/*etiology/radionuclide imaging
;
Human
;
Hypogonadism/*etiology/genetics/pathology
;
Klinefelter Syndrome/*complications/genetics/pathology
;
Male

Result Analysis
Print
Save
E-mail